Allergan, Inc Pershing Square Calls for Allergan Board to Engage with Valeant on its Offer, Calls for Nonbinding Shareholder Referendum on Merger - filing
- Follow up: Allergan calls Pershing's effort a self-serving exercise
***Valeant first made its $48.30 in cash and 0.83 Shares of Valeant Stock $46 billion hostile bid public back on April 22nd. Subsequent reports have focused on rumors Allergan was soliciting rival bids from Shire, JNJ or SNY